Trospium chloride versus oxybutynin: a randomized, double‐blind, multicentre trial in the treatment of detrusor hyper‐reflexia

Abstract

Trospium chloride and oxybutynin, judged in terms of objective urodynamic parameters, are of substantially equal value as parasympathetic antagonists. However, assessment of tolerance in terms of adverse drug effects showed that TCl had certain advantages.